NCT02559440 - Mometasone Furoate and Oxymetazoline in the Treatment of Adenoid Hypertrophy | Biotech Hunter

Enrollment

240

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

February 28, 2015

Study Completion Date

August 31, 2015

Conditions

Adenoidal Hypertrophy

Interventions

DRUG

mometasone furoate

50μg, 1 puff in each nostril every evening

DRUG

Placebo

1 puff in each nostril every evening

DRUG

Oxymetazoline + Placebo

1 puff of Oxymetazoline +1 puff of Placebo in each nostril every evening

DRUG

Placebo + placebo

1 puff of placebo +1 puff of Placebo in each nostril every evening

DRUG

mometasone furoate + Placebo

1 puff of mometasone furoate +1 puff of Placebo in each nostril every evening

DRUG

mometasone furoate + Oxymetazoline

1 puff of mometasone furoate +1 puff of Oxymetazoline in each nostril every evening

All Listed Sponsors

lead

Guangzhou Women and Children's Medical Center

OTHER